Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia.
Hussain Mubarak Al-AamriHeng KuHelen R IrvingJoseph TucciTerri Meehan-AndrewsChristopher BradleyPublished in: BMC cancer (2019)
The delay in DSB repair and lower sensitivity to daunorubicin seen in the B lymphocyte derived SUP-B15 cells could be due to loss of function of p53 that may be correlated to increased expression of SOD2 and lower ROS production.